{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:12:28Z","timestamp":1759565548000},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/gme.0b013e318178863e","type":"journal-article","created":{"date-parts":[[2008,7,2]],"date-time":"2008-07-02T07:06:34Z","timestamp":1214982394000},"page":"810-815","source":"Crossref","is-referenced-by-count":7,"title":["Chemoprevention in postmenopausal women"],"prefix":"10.1097","volume":"15","author":[{"given":"Priya","family":"Rastogi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210227","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","article-title":"Overview of the main outcomes in breast cancer prevention trials.","volume":"361","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"R2-8-20210227","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R3-8-20210227","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"R4-8-20210227","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.","volume":"97","author":"Fisher","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R5-8-20210227","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(98)85012-5","article-title":"Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomized chemoprevention trial.","volume":"352","author":"Powles","year":"1998","journal-title":"Lancet"},{"key":"R6-8-20210227","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jnci\/djk050","article-title":"Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.","volume":"99","author":"Powles","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R7-8-20210227","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(98)04394-3","article-title":"Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomized trial among hysterectomized women. Italian Tamoxifen Prevention Study.","volume":"352","author":"Veronesi","year":"1998","journal-title":"Lancet"},{"key":"R8-8-20210227","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0140-6736(02)08159-X","article-title":"Tamoxifen for breast cancer among hysterectomized women.","volume":"359","author":"Veronesi","year":"2002","journal-title":"Lancet"},{"key":"R9-8-20210227","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/jnci\/95.2.160","article-title":"Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.","volume":"95","author":"Veronesi","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R10-8-20210227","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/jnci\/djk154","article-title":"Tamoxifen for the prevention of breast cancer: late results of the Italian randomized tamoxifen prevention trial among women with hysterectomy.","volume":"99","author":"Veronesi","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R11-8-20210227","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(02)09962-2","article-title":"First results from the International Breast Cancer Intervention study (IBIS-I): a randomized prevention trial.","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"R12-8-20210227","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/jnci\/djk049","article-title":"Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial.","volume":"99","author":"Cuzick","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R13-8-20210227","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/gme.0b013e31817e6683","article-title":"Randomized clinical trials of raloxifen: reducing the risk osteoporosis and breast cancer in postmenopausal women.","volume":"15","author":"Olevsky","year":"2008","journal-title":"Menopause"},{"key":"R14-8-20210227","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs. raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP study of tamoxifen and raloxifene (STAR) P-2 trial.","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"R15-8-20210227","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1001\/jama.295.23.joc60075","article-title":"Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial.","volume":"295","author":"Land","year":"2006","journal-title":"JAMA"},{"key":"R16-8-20210227","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1006478317173","article-title":"Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial.","volume":"65","author":"Cauley","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"R17-8-20210227","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing Outcomes Relevant to Evista: a randomized trial of raloxifene in postmenopausal women with osteoporosis.","volume":"96","author":"Martino","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R18-8-20210227","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/jnci\/91.21.1829","article-title":"Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.","volume":"91","author":"Gail","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R19-8-20210227","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.amjsurg.2003.12.025","article-title":"Current comprehensive assessment and management of women at increased risk for breast cancer.","volume":"187","author":"Hollingsworth","year":"2004","journal-title":"Am J Surg"},{"key":"R20-8-20210227","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/gme.0b013e3181788d88","article-title":"Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.","volume":"15","author":"Vogel","year":"2008","journal-title":"Menopause"},{"key":"R21-8-20210227","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.suc.2007.01.010","article-title":"Breast cancer risk assessment and risk reduction.","volume":"87","author":"Newman","year":"2007","journal-title":"Surg Clin N Am"},{"key":"R22-8-20210227","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N Engl J Med"},{"key":"R25-8-20210227","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.","volume":"349","author":"Goss","year":"2003","journal-title":"N Engl J Med"},{"key":"R26-8-20210227","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.","volume":"350","author":"Coombes","year":"2004","journal-title":"N Engl J Med"},{"key":"R27-8-20210227","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.","volume":"359","author":"Baum","year":"2002","journal-title":"Lancet"},{"key":"R28-8-20210227","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/978-3-642-55647-0_9","article-title":"Aromatase inhibitors in prevention-data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study).","volume":"163","author":"Cuzick","year":"2003","journal-title":"Recent Results Cancer Res"},{"key":"R29-8-20210227","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1200\/JCO.2005.11.027","article-title":"Aromatase inhibitors for breast cancer prevention.","volume":"23","author":"Cuzick","year":"2005","journal-title":"J Clin Oncol"},{"key":"R30-8-20210227","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3747\/co.2007.117","article-title":"The National Cancer Institute of Canada Clinical Trials Group MAP.3 trial: an international breast cancer prevention trial.","volume":"14","author":"Richardson","year":"2007","journal-title":"Curr Oncol"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/gme.0b013e318178863e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:34:13Z","timestamp":1620977653000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-200815041-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e318178863e","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}